Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Immunotherapy Safety for the Primary Care ... - U.S. Coast Guard
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
a common practice to alternate <strong>the</strong> arm into which a particular vaccine is given, <strong>the</strong>re<br />
is no evidence that this is necessary.<br />
● In patients with asthma (unstable asthma in particular), peak expiratory flow rate<br />
measurements may be considered be<strong>for</strong>e an injection. If a patient’s peak expiratory<br />
flow rate is significantly below baseline, <strong>the</strong> clinical condition of <strong>the</strong> patient should be<br />
evaluated be<strong>for</strong>e administration of <strong>the</strong> injection.<br />
● Description of any reactions. Dose adjustments may be necessary if reactions are<br />
frequent or severe.<br />
● Details of any treatment given in response to a reaction should be documented in <strong>the</strong><br />
medical record and referenced on <strong>the</strong> administration <strong>for</strong>m.<br />
● Any adjustment from <strong>the</strong> standard schedule and <strong>the</strong> reason <strong>for</strong> <strong>the</strong> adjustment (e.g.,<br />
missed appointments).<br />
● Clinical status of <strong>the</strong> patient be<strong>for</strong>e <strong>the</strong> injection. In general, patients who have high<br />
fever or any significant systemic illness should not receive an injection. It is desirable<br />
to document <strong>the</strong> patient’s clinical condition be<strong>for</strong>e each injection, particularly if <strong>the</strong><br />
patient is symptomatic.<br />
● Whe<strong>the</strong>r <strong>the</strong> patient has taken an antihistamine that day<br />
● Whe<strong>the</strong>r any new medication has been taken since <strong>the</strong> last immuno<strong>the</strong>rapy injection<br />
Labels <strong>for</strong> Vaccine Vials<br />
Each vial of vaccine should be labeled in a way that permits easy identification. Each label<br />
should include <strong>the</strong> following in<strong>for</strong>mation:<br />
● Appropriate patient identifiers, including patient name, prescription or social security<br />
number, or birth date<br />
● General description of <strong>the</strong> vaccine contents. Because of space limitations, it may be<br />
necessary to abbreviate <strong>the</strong> antigens. Possible abbreviations are as follows: tree, T;<br />
grass, G; bermuda, B; weeds, W; ragweed, R; mold, M; Alternaria, Alt;<br />
Cladosporium, Cla; Penicillium, Pcn; cat, C; dog, D; cockroach, Cr; dust mite, DM; D.<br />
farinae, Df; D. pteronyssinus, Dp; mixture, Mx. A full and detailed description of vial<br />
contents should be recorded on <strong>the</strong> prescription/content <strong>for</strong>m.<br />
● The dilution from <strong>the</strong> maintenance concentrate in volume per volume. If colors,<br />
numbers, or letters are used to identify <strong>the</strong> dilution, <strong>the</strong>y also should be included.<br />
● Vaccine expiration date<br />
Instruction Form <strong>for</strong> Use at an Outside Facility<br />
An instruction <strong>for</strong>m should accompany all patients who go to an outside facility <strong>for</strong><br />
immuno<strong>the</strong>rapy injections. It should include:<br />
● General instructions <strong>for</strong> administration of immuno<strong>the</strong>rapy<br />
● Directions <strong>for</strong> adjusting <strong>the</strong> dose if <strong>the</strong>re is a reaction<br />
● Directions <strong>for</strong> adjusting <strong>the</strong> dose after an unexpected interval between injections<br />
● Instructions <strong>for</strong> treating reactions if <strong>the</strong>y occur<br />
● Name and contact in<strong>for</strong>mation of <strong>the</strong> prescribing Allergist.